MedTrace Logo

Problem-Solving Therapy for Patients With Chronic Disease and Poor Mental Well-being in General Practice

NCT05611112 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 147

Last updated 2026-05-07

No results posted yet for this study

Summary

In Denmark the vast majority of patients with chronic ischemic heart disease and/or type 2 diabetes are managed in general practice. 20% of the patients suffer from poor mental health.

Problem-solving therapy (PST) is a psychotherapeutic method that is proven effective in adults with poor mental health. PST can be provided in general practice.

The main objective of this study is to test effectiveness of providing PST to this group patients.

Conditions

  • Mental Health Impairment
  • Diabetes Type 2
  • Ischemic Heart Disease

Interventions

BEHAVIORAL

Problem Solving Therapy

Problem Solving Therapy is a well-established evidence-based therapy form that is highly effective in patients with mental health issues. Initially, the patient makes a problem list and for each problem, possible solutions will be outlined. Considering pros and cons for each solution, the patient is asked to choose the one considered most appropriate. The patient is encouraged to put this solution into action and a follow-up consultation is planned.

Sponsors & Collaborators

  • Research Unit for General Practice, Aarhus University

    collaborator OTHER

  • Danish Heart Foundation

    collaborator OTHER

  • TrygFonden, Denmark

    collaborator INDUSTRY

  • Central Denmark Region

    collaborator OTHER

  • University of Aarhus

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-01
Primary Completion
2024-09-01
Completion
2025-03-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05611112 on ClinicalTrials.gov